ADCETRIS (BRENTUXIMAB VEDOTIN) — FDA Approval BLA125388 (SEATTLE GENETICS)
ADCETRIS (BRENTUXIMAB VEDOTIN) — FDA Approval BLA125388 (SEATTLE GENETICS) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: ADCETRIS; Active ingredients: BRENTUXIMAB VEDOTIN; Application number: BLA125388.
| Brand name | ADCETRIS |
|---|---|
| Active ingredients | BRENTUXIMAB VEDOTIN |
| Application number | BLA125388 |
| Sponsor | SEATTLE GENETICS |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20110819 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →